Reply to "SARS-CoV-2 reinfection or persistence among immunodeficient patients"
J Allergy Clin Immunol Pract
.
2023 Mar;11(3):972-973.
doi: 10.1016/j.jaip.2022.11.049.
Authors
Nufar Marcus-Mandelblit
1
,
Liat Ashkenazi-Hoffnung
2
,
Oded Scheuerman
3
Affiliations
1
Schneider Children's Medical Center of Israel, Kipper Institute of Immunology, Petah Tikva, Israel. Electronic address: nufarmar@gmail.com.
2
Department of Day Hospitalization, Pediatric Infectious Disease Unit, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
3
Pediatrics B, Pediatric Infectious Disease Unit, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
PMID:
36894285
PMCID:
PMC9989502
DOI:
10.1016/j.jaip.2022.11.049
No abstract available
Publication types
Letter
MeSH terms
COVID-19*
Humans
Reinfection
SARS-CoV-2